Abstract:Oral Chinese patent medicine is the essence of effective prescriptions created and summarized by Chinese medical scientists through thousands of years of medical practice. It is portable and convenient, with an obvious curative effect and other characteristics. However, at present, oral Chinese patent medicine is rich in dosage forms, various in types, complex in mechanism of action, and broad in clinical positioning. In clinical application, there are often cases of drug use without reference to instructions,repeated drug use, and prolonged drug use, which highlights safety problems such as adverse reactions and hepatorenal toxicity. Oral Chinese patent medicine pharmacovigilance is facing challenges. World Health Organization(WHO) has issued the WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems, and International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use(ICH) has issued the ICH E2 pharmacovigilance guidelines. The United States has issued the Pharmacovigilance management standards and pharmacoepidemiological assessment guidelines, and the European Union has issued the Guidelines on good pharmacovigilance practices. Japan, South Korea, and other countries in the Asia Pacific region have established their own pharmacovigilance systems, but currently, there are no pharmacovigilance guidelines related to oral Chinese patent medicine in China. Therefore, experts from many disciplines and fields in China were invited to jointly develop the Pharmacovigilance guidelines for clinical application of oral Chinese patent medicines, which aims to develop pharmacovigilance guidelines for clinical application that are consistent with China's national conditions and highlight the characteristics of oral Chinese patent medicine, and provide guidance for clinically safe and rational drug application in medical institutions.

Discussion on Related Concepts of Compound Preparation

Preparation of Sustained Release Capsules by Electrostatic Dry Powder Coating, Using Traditional Dip Coating As Reference

Investigation and Analysis of Generic Name Suffix of Drugs in a Comprehensive Hospital

Research Progress on Quality Control Methods for Xiaochaihu Preparations

[Key technologies in dosage form design of Chinese medicinal liquid preparations: application of component solubility and solubilization technology].

Multi-compound and drug-combination pharmacokinetic research on Chinese herbal medicines

[Research on preparation of Shandantong sustained-release tablets]

[Pharmacovigilance guidelines for clinical application of oral Chinese patent medicines]

An Overview on Polymorph Preparation Methods of Active Pharmaceutical Ingredients

The preparation, characterization, and application of porous core–shell composite particles produced with laboratory-scale spray dryer

Discussion on the definition of Traditional Chinese Medicine preparation for external use to cosmetic dermatology

The Present and the Future: OTC Drug List in China

Optimization of Preparation Process and Pharmacokinetics of APAP Double-Release Pellet Capsules

Comparison of the Drug Package Inserts of Domestic and Foreign Compound Preparations Containing Narcotic Drugs

[Study on Famous Prescription of Prestigious Traditional Chinese Medicine Based on QbD Concept: Optimization of Extraction Process and Granule Forming Process of Tuomin Dingchuan Prescription].

On the Amendments of China’s Provisions for Drug Registration

Progression on Studies of Effective Components of Chinese Herbal Compound

Discussion on the working mode of lung inhalation preparation management involving foreign pharmacists

Research and Analysis of 180 Package Inserts of Oral Chemical Prescription Drug

[Research progress on clinically effective single preparations of traditional Chinese medicine]

A Unique Issue in the Standardization of Chinese Materia Medica: Processing